1.0(top 50%)
impact factor
2.6K(top 10%)
papers
21.6K(top 10%)
citations
43(top 20%)
h-index
1.0(top 50%)
impact factor
2.7K
all documents
23.3K
doc citations
65(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Passive targeting of nanoparticles to cancer: A comprehensive review of the literatureMolecular and Clinical Oncology2014282
2Specific organ metastases and survival in metastatic non-small-cell lung cancerMolecular and Clinical Oncology2015218
3Tumor markers for hepatocellular carcinomaMolecular and Clinical Oncology2013204
4Glioma and glioblastoma - how much do we (not) know?Molecular and Clinical Oncology2013154
5The role of peroxiredoxins in cancerMolecular and Clinical Oncology2017145
6Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)Molecular and Clinical Oncology2017114
7Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)Molecular and Clinical Oncology2019101
8Epigenetic control of epithelial-mesenchymal-transition in human cancerMolecular and Clinical Oncology2013100
9FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosisMolecular and Clinical Oncology201399
10The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancerMolecular and Clinical Oncology201496
11Oral mucositis in cancer treatment: Natural history, prevention and treatmentMolecular and Clinical Oncology201494
12Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysisMolecular and Clinical Oncology201590
13Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancerMolecular and Clinical Oncology201583
14Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patientsMolecular and Clinical Oncology201782
15TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysisMolecular and Clinical Oncology201676
16Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemopreventionMolecular and Clinical Oncology201375
17Clinical applications of nucleic acid aptamers in cancerMolecular and Clinical Oncology201474
18Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoringMolecular and Clinical Oncology201567
19Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasisMolecular and Clinical Oncology201464
20The proliferation marker thymidine kinase 1 in clinical useMolecular and Clinical Oncology201363
21Features of ovarian cancer in Lynch syndrome (Review)Molecular and Clinical Oncology201463
22Cardiotoxicity associated with targeted cancer therapiesMolecular and Clinical Oncology201663
23Multiple microRNAs as biomarkers for early breast cancer diagnosisMolecular and Clinical Oncology202063
24Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysisMolecular and Clinical Oncology201561
25The biology of uterine sarcomas: A review and updateMolecular and Clinical Oncology201359
26The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancerMolecular and Clinical Oncology201559
27Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapyMolecular and Clinical Oncology201659
28Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad‑spectrum cancer gene therapy - A review of molecular mechanisms for oncologistsMolecular and Clinical Oncology201857
29Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosisMolecular and Clinical Oncology201456
30Expression of aquaporin-1 is a poor prognostic factor for stage II and III colon cancerMolecular and Clinical Oncology201355
31Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancerMolecular and Clinical Oncology201455
32Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategiesMolecular and Clinical Oncology201555
33Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysisMolecular and Clinical Oncology201453
34Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup SurveillanceMolecular and Clinical Oncology201352
35Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinomaMolecular and Clinical Oncology201352
36Potency of non-steroidal anti-inflammatory drugs in chemotherapyMolecular and Clinical Oncology201551
37Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancersMolecular and Clinical Oncology201349
38A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stressMolecular and Clinical Oncology201449
39The evolution of proton beam therapy: Current and future status (Review)Molecular and Clinical Oncology201849
40Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survivalMolecular and Clinical Oncology201348
41Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)Molecular and Clinical Oncology201448
42Clinical characteristics and prognostic analysis of Krukenberg tumorMolecular and Clinical Oncology201548
43The optimum marker for the detection of lymphatic vesselsMolecular and Clinical Oncology201748
44Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer centerMolecular and Clinical Oncology201447
45Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancerMolecular and Clinical Oncology201447
46Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter studyMolecular and Clinical Oncology201447
47General insight into cancer: An overview of colorectal cancer (Review)Molecular and Clinical Oncology202147
48Oxidative stress response induced by chemotherapy in leukemia treatment (Review)Molecular and Clinical Oncology201846
49Profiling analysis of circulating microRNA expression in cervical cancerMolecular and Clinical Oncology201645
50Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancerMolecular and Clinical Oncology201344